March 12, 2018 / 8:07 PM / a year ago

BRIEF-Iovance Biotherapeutics Reports Q4 Non-Gaap Loss Per Share $0.32

1 Min Read

March 12 (Reuters) - Iovance Biotherapeutics Inc:

* IOVANCE BIOTHERAPEUTICS REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

* Q4 NON-GAAP LOSS PER SHARE $0.32

* Q4 GAAP LOSS PER SHARE $0.36

* Q4 EARNINGS PER SHARE VIEW $-0.32 — THOMSON REUTERS I/B/E/S

* Q4 EARNINGS PER SHARE VIEW $-0.32 — THOMSON REUTERS I/B/E/S

* IOVANCE - ANTICIPATES CASH, CASH EQUIVALENTS AND INVESTMENTS TO BE BETWEEN $190 MILLION AND $210 MILLION AT DECEMBER 31 Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below